The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Viridian Therapeutics Inc (NASDAQ: VRDN) closed at $22.30 down -0.89% from its previous closing price of $22.50. In other words, the price has decreased by -$0.89 from its previous closing price. On the day, 2.76 million shares were traded. VRDN stock price reached its highest trading level at $23.43 during the session, while it also had its lowest trading level at $21.985.
Ratios:
For a deeper understanding of Viridian Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 23.99 and its Current Ratio is at 23.99. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on September 11, 2024, Reiterated its Buy rating but revised its target price to $38 from $30 previously.
On June 11, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $29.
On June 06, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $23.Goldman initiated its Buy rating on June 06, 2024, with a $23 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 13 ’24 when Fairmount Funds Management LLC bought 1,600,000 shares for $18.75 per share. The transaction valued at 30,000,000 led to the insider holds 3,445,813 shares of the business.
Fairmount Funds Management LLC bought 476,190 shares of VRDN for $9,999,990 on Jan 22 ’24. The Director now owns 1,839,954 shares after completing the transaction at $21.00 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VRDN now has a Market Capitalization of 1702749824 and an Enterprise Value of 1075694208. For the stock, the TTM Price-to-Sale (P/S) ratio is 5733.41 while its Price-to-Book (P/B) ratio in mrq is 3.72. Its current Enterprise Value per Revenue stands at 3735.049 whereas that against EBITDA is -4.299.
Stock Price History:
Over the past 52 weeks, VRDN has reached a high of $24.18, while it has fallen to a 52-week low of $10.93. The 50-Day Moving Average of the stock is 38.63%, while the 200-Day Moving Average is calculated to be 34.16%.
Shares Statistics:
For the past three months, VRDN has traded an average of 1.49M shares per day and 4156920 over the past ten days. A total of 74.56M shares are outstanding, with a floating share count of 64.83M. Insiders hold about 13.04% of the company’s shares, while institutions hold 84.43% stake in the company. Shares short for VRDN as of 1724976000 were 8034096 with a Short Ratio of 5.40, compared to 1722384000 on 8488252. Therefore, it implies a Short% of Shares Outstanding of 8034096 and a Short% of Float of 14.760000000000002.
